Literature DB >> 32104574

CON: All Patients With Immune-Tolerated Hepatitis B Virus Do Not Need to Be Treated.

Bashar M Attar1.   

Abstract

http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-1-reading-attar a video presentation of this article.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2020        PMID： 32104574      PMCID： PMC7041959          DOI： 10.1002/cld.893

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  33 in total

1.  High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.

Authors:  J Y Park; Y N Park; D Y Kim; Y H Paik; K S Lee; B S Moon; K-H Han; C Y Chon; S H Ahn
Journal:  J Viral Hepat       Date:  2008-06-28       Impact factor: 3.728

2.  Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection.

Authors:  Philip Rosenthal; Simon C Ling; Steven H Belle; Karen F Murray; Norberto Rodriguez-Baez; Sarah J Schwarzenberg; Jeffrey Teckman; Hsing-Hua S Lin; Kathleen B Schwarz
Journal:  Hepatology       Date:  2019-02-20       Impact factor: 17.425

3.  Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus.

Authors:  H Y Hsu; M H Chang; K H Hsieh; C Y Lee; H H Lin; L H Hwang; P J Chen; D S Chen
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

Review 4.  Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion.

Authors:  C-M Chu; Y-F Liaw
Journal:  J Viral Hepat       Date:  2007-03       Impact factor: 3.728

5.  Four-year Outcomes After Cessation of Tenofovir in Immune-tolerant Chronic Hepatitis B Patients.

Authors:  Vincent Wai-Sun Wong; Aric J Hui; Grace Lai-Hung Wong; Rosita Suk-Yi Chan; Angel Mei-Ling Chim; Angeline Oi-Shan Lo; Henry Lik-Yuen Chan
Journal:  J Clin Gastroenterol       Date:  2018-04       Impact factor: 3.062

6.  Immune tolerant HBV and HCC: time to revise our tolerance levels for therapy?

Authors:  Kali Zhou; Norah Terrault
Journal:  AME Med J       Date:  2018-02-10

7.  HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.

Authors:  William S Mason; Upkar S Gill; Samuel Litwin; Yan Zhou; Suraj Peri; Oltin Pop; Michelle L W Hong; Sandhia Naik; Alberto Quaglia; Antonio Bertoletti; Patrick T F Kennedy
Journal:  Gastroenterology       Date:  2016-07-22       Impact factor: 22.682

Review 8.  The immune tolerant phase of chronic HBV infection: new perspectives on an old concept.

Authors:  Antonio Bertoletti; Patrick T Kennedy
Journal:  Cell Mol Immunol       Date:  2014-09-01       Impact factor: 11.530

9.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

10.  Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.

Authors:  Chee-Kin Hui; Nancy Leung; Siu-Tsan Yuen; Hai-Ying Zhang; Kar-Wai Leung; Lei Lu; Stephen K F Cheung; Wai-Man Wong; George K Lau
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.